BIO Investor Forum Digital

October 13-15, 2020

Advisory Committee

The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions. 
 

Mahima Agochiya , PhD, Business Development & Program Manager, SPARK Translational Research Program, Stanford University

Janice Bourque, Managing Director, Life Sciences, Hercules Technology Growth Capital

Jason Camm,  Managing Director and Chief Medical Officer, Thiel Capital LLC

Jung E. Choi, Chief Business & Strategy Officer, Global Blood Therapeutics

Shelley Chu, MD, PhD, Partner, Abingworth

Jennifer R. Cochran, PhD, Shriram Chair of the Department of Bioengineering, Stanford University

Grace Colón, PhD, President & Chief Executive Officer, InCarda Therapeutics   

Rajeev Dadoo, PhD, Partner, S.R. One Limited

Gini Deshpande, PhD, Founder & Chief Executive Officer, NuMedii

Jack Florio, Managing Director, Objective Capital Partners

Gábor Gyülvészi, PhD, Senior Associate  Nextech Invest Ltd.                    

Reza Halse, PhD, Head, Pacific BD&L Hub; President, MRL Ventures Fund, Merck

Tao Huang, PhD, JD, Venture Partner, Cenova Capital

Charlotte Hubbert, PhD, Partner, Autism Impact Fund

Alexis Ji, PhD, Partner, Illumina Ventures

Ravi Kiron, PhD, Head, BioPharma External Innovation, EMD Serono

Jennifer Landress, Senior Vice President and Chief Operating Officer, Biocom

Angele Maki, PhD, Vice President, Emerging Technology & Innovation, Eli Lilly & Company

Carolyn Ng, PhD, Managing Director, Vertex Ventures HC

Mahendra Shah, PhD, Managing Directo, Vivo Capital

Ruchita Sinha, Partner, AV8 Ventures

Samuel Wu, MD, PhD, Managing Director, Acuris Partners

Asish Xavier, PhD, Vice President, Venture Investments, Johnson & Johnson Innovation